11:50 COMPANY SPOTLIGHT PRESENTATIONS
A line-up of cutting-edge biotech companies will present their pipelines, business models and investment or partnership opportunities.
?Dr Geoff Cumming, Chief Executive Officer, Anteo Diagnostics (ASX:ADO), Australia
?Evan Ballantyne, CFO, Synthetic Biologics (NYSE MKT:SYN), United States
?Miguel Sieler, Chief Executive Officer, NEOVACS (Alternext Paris : ALNEV), France
?Martin Rogers, Non-Executive Chairman, OncoSil Medical (ASX:OSL), Australia
11:50 COMPANY SPOTLIGHT PRESENTATIONSA line-up of cutting-edge...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.002(8.70%) |
Mkt cap ! $52.28M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 2.1¢ | $20.83K | 964.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2247357 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 164375 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |